[go: up one dir, main page]

SE9004060L - Bensazepin- och bensotiazepin-derivat - Google Patents

Bensazepin- och bensotiazepin-derivat

Info

Publication number
SE9004060L
SE9004060L SE9004060A SE9004060A SE9004060L SE 9004060 L SE9004060 L SE 9004060L SE 9004060 A SE9004060 A SE 9004060A SE 9004060 A SE9004060 A SE 9004060A SE 9004060 L SE9004060 L SE 9004060L
Authority
SE
Sweden
Prior art keywords
benzzepine
bensotiazepine
derivate
image
exhibited
Prior art date
Application number
SE9004060A
Other languages
English (en)
Swedish (sv)
Other versions
SE9004060D0 (sv
Inventor
D M Floyd
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Publication of SE9004060D0 publication Critical patent/SE9004060D0/xx
Publication of SE9004060L publication Critical patent/SE9004060L/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D223/00Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16Benzazepines; Hydrogenated benzazepines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D281/00Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D281/02Seven-membered rings
    • C07D281/04Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D281/08Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D281/10Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Hydrogenated Pyridines (AREA)
SE9004060A 1988-06-20 1990-12-19 Bensazepin- och bensotiazepin-derivat SE9004060L (sv)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US20852188A 1988-06-20 1988-06-20
US07/353,806 US4902684A (en) 1988-06-20 1989-05-22 Benzazepine and benzothiazepine derivatives
PCT/US1989/002270 WO1989012633A1 (en) 1988-06-20 1989-05-23 Benzazepine and benzothiazepine derivatives

Publications (2)

Publication Number Publication Date
SE9004060D0 SE9004060D0 (sv) 1990-12-19
SE9004060L true SE9004060L (sv) 1992-06-20

Family

ID=26903265

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9004060A SE9004060L (sv) 1988-06-20 1990-12-19 Bensazepin- och bensotiazepin-derivat

Country Status (29)

Country Link
US (1) US4902684A (pt)
JP (1) JP2793674B2 (pt)
KR (1) KR970002633B1 (pt)
CN (1) CN1027262C (pt)
AT (1) AT398567B (pt)
AU (1) AU614399B2 (pt)
BE (1) BE1003305A4 (pt)
CA (1) CA1336975C (pt)
CH (1) CH681723A5 (pt)
EG (1) EG19071A (pt)
ES (1) ES2016467A6 (pt)
FI (1) FI94246C (pt)
FR (1) FR2632953B1 (pt)
GB (1) GB2231329B (pt)
GR (1) GR1002099B (pt)
HU (1) HU210929B (pt)
IE (1) IE64242B1 (pt)
IL (1) IL90515A (pt)
IT (1) IT1230884B (pt)
LU (1) LU87865A1 (pt)
NL (1) NL8920642A (pt)
NO (1) NO179449C (pt)
NZ (1) NZ229612A (pt)
PL (1) PL162313B1 (pt)
PT (1) PT90914B (pt)
RU (1) RU2090562C1 (pt)
SE (1) SE9004060L (pt)
WO (1) WO1989012633A1 (pt)
YU (1) YU121389A (pt)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5008284A (en) * 1989-02-15 1991-04-16 E. R. Squibb & Sons, Inc. Method of reducing pre- and post-ischemic myocardial arrhythmias and fibrillation
US4946840A (en) * 1989-04-06 1990-08-07 E. R. Squibb & Sons, Inc. Benzazepine and benzothiazepine derivatives
US4963671A (en) * 1989-11-20 1990-10-16 E. R. Squibb & Sons, Inc. Process for resolving chiral intermediates used in making calcium channel blockers
US5112969A (en) * 1990-04-02 1992-05-12 Merrell Dow Pharmaceuticals Inc. Cyano esters and azepinones
IT1240686B (it) * 1990-04-27 1993-12-17 Luso Farmaco Inst Derivati 1,5-benzotiazepinonici, loro preparazione e uso farmaceutico
IT1244878B (it) * 1990-12-11 1994-09-12 Lusochimica Spa Processo per la preparazione del (+)-cis-3-(acetossi)-5-!2-( dimetilammino)etil!-2,3-diidro-2-(4-metossifenil)-1,5-benzotiazepin- 4-(5h)-one cloridrato
EP0593603B1 (en) * 1991-06-28 2002-11-20 Smithkline Beecham Corporation Bicyclic fibrinogen antagonists
IT1255545B (it) * 1992-10-23 1995-11-09 Procedimento per la preparazione di diltiazem
CA2098446A1 (en) * 1992-09-30 1994-03-31 Eckard Weber 2,5-dihydro-2,5-dioxo-1h-azepines and 2,5-dihydro-2-oxo-1h-azepines and the use thereof as excitatory amino acid and glycine receptor antagonists
ATE216580T1 (de) * 1993-07-16 2002-05-15 Merck & Co Inc Benzoxazinon- und benzopyrimidinon- piperidinyl- verbindungen als tokolytische oxytocin-rezeptor- antagonisten
US5854233A (en) * 1993-09-08 1998-12-29 Pharmacy And Therapeutic Advisory Consultancy Ltd. Method of treating liver disease and like indications with vasodilating agents
US6174917B1 (en) 1993-09-08 2001-01-16 Pharmacy And Therapeutic Advisory Consultancy Ltd. Method of treating liver disease and like indications with vasodilating agents
EP0751774B1 (en) * 1994-03-24 2003-08-13 Merrell Pharmaceuticals Inc. Hypocholesterolemic mercaptoacetylamide disulfide derivatives
US5580867A (en) * 1994-09-09 1996-12-03 Universite De Montreal Myocardial protection during ischemia and reperfusion
GB9423172D0 (en) 1994-11-17 1995-01-04 Wellcom Foundation The Limited Hypolipidemic benzothiazepines
WO1998025920A1 (en) * 1996-12-10 1998-06-18 Abbott Laboratories 3-pyridyl enantiomers and their use as analgesics
US6277844B1 (en) 1998-09-14 2001-08-21 Sydney Spector Compound for selective treatment of malignant cells by inhibiting cell cycle progression, decreasing Bcl2, and increasing apoptosis
GB9907895D0 (en) * 1999-04-08 1999-06-02 Texas A & M Univ Sys Novel ligands for chiral catalysis
US6472533B1 (en) 1999-04-08 2002-10-29 The Texas A & M University System Ligands for chiral catalysis
CA2482320C (en) * 2002-04-19 2010-02-09 Georg T. Wondrak Methods for modulating phototoxicity
TWI289141B (en) * 2003-03-11 2007-11-01 Hoffmann La Roche F. Ag. Quinolinone derivatives and uses thereof

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3312691A (en) * 1963-08-23 1967-04-04 Ciba Geigy Corp 2, 3, 4, 5-tetrahydro-1-benzazepin-2-ones
US3562257A (en) * 1967-10-28 1971-02-09 Tanabe Seiyaku Co Benzothiazepine derivatives
JPS59191036A (ja) * 1983-04-14 1984-10-30 Fuji Photo Film Co Ltd ハロゲン化銀写真感光材料
US4567175A (en) * 1983-06-03 1986-01-28 Tanabe Seiyaku Co., Ltd. 8-Chloro-1,5-benzothiazepine derivatives
GB8316032D0 (en) * 1983-06-11 1983-07-13 Tanabe Seiyaku Co Benzothiazepine derivatives
GB2154578A (en) * 1984-02-18 1985-09-11 Tanabe Seiyaku Co Novel 1,5-benzothiazepine derivatives and processes for preparing the same
US4590188A (en) * 1984-02-18 1986-05-20 Tanabe Seiyaku Co., Ltd. 1,5-benzothiazepine derivatives and their pharmaceutical use
GB2154577A (en) * 1984-02-18 1985-09-11 Tanabe Seiyaku Co 1,5-benzothiazepines
GB2167063A (en) * 1984-11-17 1986-05-21 Tanabe Seiyaku Co 6 or 9-chloro-1, 5-benzothiazepine derivatives
CA1271747A (en) * 1985-06-12 1990-07-17 David M. Floyd Benzazepines derivatives
US4748239A (en) * 1985-06-12 1988-05-31 E. R. Squibb & Sons, Inc. Benzazepine derivatives
US4584131A (en) * 1985-06-20 1986-04-22 E. R. Squibb & Sons, Inc. Benzothiazepine derivatives
DE3717561A1 (de) * 1987-05-25 1988-12-08 Thomae Gmbh Dr K Indol-, isochinolin- und benzazepinderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
CA1271748C (en) * 1985-12-12 1990-07-17 BENZAZEPINE DERIVATIVES
FR2597097B1 (fr) * 1986-04-15 1988-12-02 Synthelabo Derives de benzothiazepine-1, 5, leur preparation et leur application en therapeutique
EP0256888B1 (en) * 1986-08-20 1991-07-03 McNeilab, Inc. Benzothiazepine vasodilators having aralkyl substitution
US4729994A (en) * 1986-08-20 1988-03-08 Mcneilab, Inc. Benzothiazepine vasodilators having aralkyl substitution
US4694002A (en) * 1986-08-21 1987-09-15 E. R. Squibb & Sons, Inc. Benzothiazepine derivatives
US4752645A (en) * 1986-10-09 1988-06-21 E. R. Squibb & Sons, Inc. Benzazepine derivatives
ZA893392B (en) * 1988-05-24 1990-01-31 Hoffmann La Roche Process for the manufacture of optically active naphthothiazepinones

Also Published As

Publication number Publication date
HU894298D0 (en) 1991-01-28
FI94246B (fi) 1995-04-28
FR2632953B1 (fr) 1992-05-29
NO905485D0 (no) 1990-12-19
PL162313B1 (pl) 1993-09-30
GB2231329A (en) 1990-11-14
FI94246C (fi) 1995-08-10
NZ229612A (en) 1992-07-28
ES2016467A6 (es) 1990-11-01
CN1027262C (zh) 1995-01-04
KR920700207A (ko) 1992-02-19
BE1003305A4 (fr) 1992-02-25
IE64242B1 (en) 1995-07-26
PT90914B (pt) 1994-12-30
IL90515A (en) 1994-07-31
NL8920642A (nl) 1990-06-01
YU121389A (en) 1991-04-30
ATA901089A (de) 1994-05-15
RU2090562C1 (ru) 1997-09-20
LU87865A1 (de) 1991-12-16
IT8920933A0 (it) 1989-06-20
CN1039585A (zh) 1990-02-14
AU3859389A (en) 1990-01-12
PT90914A (pt) 1989-12-29
IE891957L (en) 1989-12-20
FI900813A0 (fi) 1990-02-19
SE9004060D0 (sv) 1990-12-19
AU614399B2 (en) 1991-08-29
US4902684A (en) 1990-02-20
CA1336975C (en) 1995-09-12
GB9002587D0 (en) 1990-08-29
NO905485L (no) 1991-02-19
CH681723A5 (pt) 1993-05-14
WO1989012633A1 (en) 1989-12-28
JPH04502002A (ja) 1992-04-09
NO179449C (no) 1996-10-09
GR1002099B (en) 1995-12-28
HUT59908A (en) 1992-07-28
IT1230884B (it) 1991-11-08
NO179449B (no) 1996-07-01
GR890100410A (el) 1990-05-11
IL90515A0 (en) 1990-01-18
GB2231329B (en) 1992-10-21
EG19071A (en) 1994-07-30
JP2793674B2 (ja) 1998-09-03
KR970002633B1 (en) 1997-03-06
HU210929B (en) 1995-09-28
AT398567B (de) 1994-12-27
FR2632953A1 (fr) 1989-12-22

Similar Documents

Publication Publication Date Title
SE9004060D0 (sv) Bensazepin- och bensotiazepin-derivat
FI914928A0 (fi) Hydroximetyl (metylencyklopentyl) puriner och -pyrimidiner.
ITMI910477A0 (it) Disposizione di guarnizioni
ITTO910281A0 (it) Procedimento per l'ossidazione di carboidrati
FI932104A0 (fi) Nya 4-arylpiperaziner och 4-arylpiperidiner
FI944885A7 (fi) Tölkin perusosa
NO179353C (no) Anvendelse av mikrobicide forbindelser av dimetylamin-epiklorhydrinaminer
FI934845L (fi) Fyrvaegspall som tillverkats av skivor
KR950700875A (ko) 치환된 구아니딘의 제조방법(preparation of substituted guanidines)
FI904060A7 (fi) Amidi-kompleksiyhdisteiden käyttö
FI863836A0 (fi) Kinolinderivat.
MX9101767A (es) Derivados de heteroaroilo y procedimiento para su obtencion
SE9100920D0 (sv) New active compounds
ITMI912655A1 (it) Combinazione di estrusore-calandra.
ATE164592T1 (de) Antiretrovirale acyl-verbindungen
NO306195B1 (no) Anvendelse av <alfa>-ketoglutarat
FI930092A0 (fi) Indanopyrrolidinkarbamater
LV10153A (lv) Sastavs seklu dezinfekcijai
DK0532629T3 (da) 1-Piperidinyl-alkanoylarylsulfonamid-derivater
SE8601963D0 (sv) O-sulfated beta-lactam hydroxamic acids
ITMI920605A0 (it) Associazioni di composti ad attivita' antivirale
ES2079724T3 (es) Nuevos compuestos antibioticos y su produccion.
FI931018A7 (fi) 2-deoksistreptamiini-tyyppisen antibiootin käyttö
FI913285A0 (fi) Svavelsubstituerade mevinsyraderivat.
SE9000857D0 (sv) Novel use of theraeutically active compound

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 9004060-1